Want to join our latest investment opportunities?

Discover startups that we recently backed. We’ve checked the details of each description at time of writing, though these may change. Please enjoy as general information only.

Our fund is open for investment. For more information see here or if you have questions then please get in touch.

    • 25-Nov-20

      Access EIS invested in MPowder A unique range of high protein vegan powders designed to nourish your body, naturally, during menopause. MPowder

    • 20-Nov-20

      Access EIS invested in Spirea Targeting cancer cells in chemotherapy with more flexibility and increasing the range of treatable patients. Spirea

    • 15-Oct-20

      Access EIS invested in NearSt Showing in-store products in search results to attract nearby customers. Partnered with Shopify and Microsoft Dynamics. NearSt

    • 7-Oct-20

      Access EIS invested in CatchApp Scheduling genius for meetings and appointments. CatchApp

    • 6-Oct-20

      Access EIS invested in Tymit Credit card that breaks purchases into monthly installments. Tymit

    • 30-Sep-20

      Access EIS invested in Themis Mitigate the risks and impact of all financial crime. Themis

    • 30-Sep-20

      Access EIS invested in Nivoda The trusted B2B platform for the global jewellery industry. Nivoda

    • 26-Sep-20

      Access EIS invested in Pillar Personalised training and nutrition app for amateur endurance sports. Pillar

    • 17-Sep-20

      Access EIS invested in FuroSystems Reinvent your commute with ultra-lightweight folding electric bikes and scooters. FuroSystems

    • 07-Sep-20

      Access EIS invested in Camallergy Developing life-saving treatments for food allergies. Featured in BBC, Wall Street Journal, and New Scientist. Camallergy


    Investing in
    Access EIS.

    Once you've read about the fund, our online investment form takes around 10 minutes to complete.

    Get started
    A golden clock
    Have questions
    about Access EIS?